GenomeIndia Project
Current Affairs & Government Schemes › Digital India and Technology Schemes · Topic 10.11
The GenomeIndia Project is a national genome sequencing programme of the Department of Biotechnology (DBT), Ministry of Science and Technology, to build a reference map of genetic variation in the Indian population. Its first phase sequenced the whole genomes of about 10,000 healthy people from about 83 population groups, and 10,074 genomes were reported. The data were released on 9 January 2025 through the Indian Biological Data Centre at Faridabad, under the Biotech-PRIDE guidelines, with access given to approved researchers. The project is coordinated by the Centre for Brain Research at the Indian Institute of Science, Bengaluru, with about 20 partner institutions.
5 min read · UPSC Prelims · Current Affairs & Government Schemes · Digital India and Technology Schemes
At a Glance
- Department Biotechnology
- Phase one About 10,000 genomes
- Data released 9 January 2025
- Data centre Indian Biological Data Centre
- Guidelines Biotech-PRIDE
- Exam link UPSC Prelims, Current Affairs and Government Schemes: Digital India and Technology Schemes
Where Does It Fit?
This is the eleventh topic of the macro on Digital India and technology. It links the digital and data theme with biotechnology, and shows how large national datasets are built and governed. Previous topic: PM-WANI (Wi-Fi Access Network Interface). Next topic: Central Bank Digital Currency – Digital Rupee (e₹) Pilot Project.
What Is the GenomeIndia Project?
| Feature | Detail |
|---|---|
| Nodal body | Department of Biotechnology, Ministry of Science and Technology |
| Aim | Build a reference of genetic variation in India for use in medicine, so that disease risk and drug response can be linked to Indian population groups |
| Phase one | Sequencing of about 10,000 whole genomes of healthy volunteers, which exceeded 10,000 with 10,074 reported |
| Coverage | Samples from about 83 population groups across the country, because India has a large number of endogamous groups with distinct gene pools |
| Coordination | The Centre for Brain Research at the Indian Institute of Science, Bengaluru, leads about 20 institutions in the consortium |
| Data release | Announced on 9 January 2025, with the data held at the Indian Biological Data Centre at Faridabad |
| Sample store | A biobank with blood samples, reported at about 20,000, supports follow-up work |
How Is the Data Governed and Used?
- Biotech-PRIDE: The Biotech Research Innovation and Development guidelines set rules for sharing biological data, with the data held under a managed access system, and anonymised
- Access: Researchers apply with a proposal, which is reviewed by an independent panel before they get access to the data
- Uses: Finding gene variants linked to diseases, designing genetic tests, guiding drug choice and building polygenic risk scores for Indian groups
- Rare diseases: Genome data helps with the diagnosis of rare genetic disorders, which are common among groups with small gene pools
- Next steps: The Department has stated that it plans to widen the database beyond the first phase
- Link with data rules: Handling personal data is also guided by the Digital Personal Data Protection Act, 2023
What Else Should You Remember?
- Reference genome gap: Most global reference data come from people of European origin, so Indian genetic variants are poorly represented, which is a reason for a national dataset
- Human Genome Project: The international Human Genome Project, completed in 2003, gave the first human reference sequence
- Whole genome: Whole genome sequencing reads the entire DNA of a person, and not just some genes
- Founder effect: Many Indian groups have descended from small founding populations, which leads to higher rates of some recessive diseases
- Precision medicine: Treatment based on genes needs population data to interpret results correctly
- IBDC: The Indian Biological Data Centre is the national repository for life science data, set up at the Regional Centre for Biotechnology, Faridabad
- Ethics: Concerns include consent, privacy of genetic information, risk of discrimination and misuse of group-level data
- Group harm: Findings about a community could be used to stigmatise it, so community consent and safeguards are discussed
- Related: Other national efforts include sequencing of the SARS-CoV-2 virus through the INSACOG consortium and the National Sickle Cell Anaemia Elimination Mission, which uses genetic screening
- Sampling: Volunteers were recruited with informed consent from many regions, and the project tried to cover tribal, caste, religious and regional groups so that the dataset reflects the diversity of the Indian population as far as possible
- Next phases: Later work may add people with disease, larger numbers per group, and links to health records, which would raise further questions about consent and the protection of sensitive health data
- Concerns: Healthy volunteers only, small sample against 140 crore people, limits on data access and use by foreign firms
- Exam trap: GenomeIndia is a DBT project and not a project of the Indian Council of Medical Research or the Ministry of Health
Why Does It Matter for the Exam?
- Department: Biotechnology
- Size: About 10,000 genomes, 83 groups
- Release: 9 January 2025 at IBDC
- Guidelines: Biotech-PRIDE
- Common errors: Giving ICMR as the lead or saying it is fully open data
As an analytical point, a national genome dataset can bring accurate diagnosis and precision medicine, but only if consent, privacy and community safeguards are strong. Wider sampling and affordable genetic testing are the next steps.
Why Is This Topic Important?
- Facts Department and size
- Governance Managed access
- Uses Precision medicine
What Came Next?
The last topic covers the digital form of the national currency. Next topic: Central Bank Digital Currency – Digital Rupee (e₹) Pilot Project.
Key People and Terms
- GenomeIndia National genome project
- DBT Department of Biotechnology
- IBDC Indian Biological Data Centre
- Whole genome Entire DNA sequence
- Biotech-PRIDE Data sharing guidelines
Exam Corner
Points to Remember
- Department: DBT.
- Genomes: about 10,000, 83 groups.
- Data released: 9 January 2025.
- Repository: IBDC.
- Lead: Centre for Brain Research, IISc.
Do Not Confuse With
- GenomeIndia and the Human Genome Project National Indian dataset versus the global reference sequence
- GenomeIndia and INSACOG Human genomes versus virus sequencing
- GenomeIndia and gene editing Reading genes versus changing them
Memory Hook
Ten thousand Indians, eighty-three groups, one reference: the genome map of India.
Mains Angle
Questions ask about the promise and ethics of genomic data. These points give a balanced frame.
- Benefits Precision medicine and rare disease care
- Risks Privacy, group harm and misuse
- Way forward Strong consent rules, wider sampling and affordable testing
A Question You May Face
An original practice question, not a past paper question.
“Discuss the significance of the GenomeIndia Project for healthcare in India and the ethical safeguards required for genomic data.”
How to Answer
- Introduce Project and data.
- Significance Precision medicine.
- Safeguards Consent, privacy, group harm.
- Way Wider samples and access rules.
GS Relevance
Frequently Asked Questions
What is the GenomeIndia Project?
The GenomeIndia Project is a national programme of the Department of Biotechnology to build a reference of genetic variation in India. Its first phase sequenced about 10,000 whole genomes from about 83 population groups, and the data were released on 9 January 2025 through the Indian Biological Data Centre at Faridabad.
Which department runs the GenomeIndia Project?
The Department of Biotechnology in the Ministry of Science and Technology runs it. The Centre for Brain Research at the Indian Institute of Science, Bengaluru, coordinates a consortium of about 20 institutions, and the Indian Biological Data Centre stores the data. It is not a project of the Indian Council of Medical Research.
How many genomes were sequenced under GenomeIndia?
The first phase aimed at 10,000 whole genomes and reports state that 10,074 genomes were sequenced, from healthy volunteers belonging to about 83 population groups. A biobank of about 20,000 blood samples was also built. The Department has said that the database may be widened beyond this first phase.
What are the Biotech-PRIDE guidelines?
The Biotech Research Innovation and Development, or Biotech-PRIDE, guidelines set rules for sharing biological data in India. For GenomeIndia, data are anonymised and kept under managed access, so researchers must apply with a proposal that an independent panel reviews before they receive access to the data.
What is the latest status of GenomeIndia?
After the data release on 9 January 2025, researchers can apply for access through the Indian Biological Data Centre. The Department of Biotechnology has indicated plans to expand the work beyond the first 10,000 genomes. Check the Department and the data centre for later phases and any new rules.
PYQ Practice — Statement Analysis
1 The GenomeIndia Project is led by the Department of Biotechnology.
The Centre for Brain Research coordinates it.
2 GenomeIndia sequenced about 10,000 whole genomes in its first phase.
The data were released on 9 January 2025.
3 GenomeIndia data are freely open to anyone.
Access is managed through a proposal process.
4 GenomeIndia is run by the Indian Council of Medical Research.
It is a project of the Department of Biotechnology.
Related Topics
Browse the full Current Affairs & Government Schemes index